Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Asia-pacific Neurovascular Devices / Interventional Neurology Market Forecast 2021-2028

Published by Inkwood Research Product code 1018651
Published Content info 171 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia-pacific Neurovascular Devices / Interventional Neurology Market Forecast 2021-2028
Published: July 19, 2021 Content info: 171 Pages
Description

KEY FINDINGS

The Asia-Pacific neurovascular devices / interventional neurology market growth is anticipated to progress at a CAGR of 5.29% during the forecast period, 2021-2028. The increasing geriatric population is the dominant factor fueling the market growth.

MARKET INSIGHTS

Australia & New Zealand, India, China, Thailand, Indonesia, Japan, Vietnam, South Korea, and Rest of Asia-Pacific are evaluated for the Asia-Pacific neurovascular devices / interventional neurology market growth analysis. In India, due to the prevalence of neurovascular diseases, there are increased market demands. This is also attributed to the less preventive strategies and unorganized management for stroke. There is rising utilization of endovascular treatment techniques. The drastic adoption of endovascular coiling has led to a transition in interventional neuroradiology.

Further, there is less awareness about stroke and even lesser awareness of neurovascular diseases in rural areas. Therefore, government initiatives are projected to influence market demands.

In Australia, the market growth is accredited to increasing burn injury cases. As per the Australian Bureau of Statistics, more than 700,000 Australians have brain injuries. The prevalence is due to the geriatric population and misbalance in their mobility. Neurological disorders account for almost 20.5% of the total disability globally. With rising concerns, there has been a rise in the number of research institutes for neurological disorders.

In Thailand, the number of Alzheimer's patients is estimated to rise to 1,117,000 by 2030, thereby escalating market demands. According to the World Bank, the population is again rapidly. This increases the risk of neurological disorders like Alzheimer's disease. Moreover, stroke is a major health burden in the country. Such factors make these countries conducive market for neurovascular devices.

COMPETITIVE INSIGHTS

Some of the prominent companies in the market include: Microport Scientific Corporation, Penumbra Inc, Asahi Intecc, Memry Corporation, B Braun Melsungen AG, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 38562

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCIDENCE OF NEUROVASCULAR CONDITIONS
    • 3.1.2. DEMAND FOR MINIMALLY INVASIVE PROCEDURES
    • 3.1.3. SIGNIFICANCE OF NEUROLOGICAL DISEASES IN GERIATRIC POPULATION
    • 3.1.4. PREVALENCE OF UNDERLYING DISEASE CONDITIONS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. EXORBITANT COST OF NEUROVASCULAR DEVICES
    • 3.2.2. LACK OF ADEQUATE NUMBER OF TRAINED NEUROSURGEONS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRY
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY PRODUCT

  • 5.1. EMBOLIZATION DEVICES
  • 5.2. ACCESSORY DEVICES
  • 5.3. REVASCULARIZATION DEVICES
  • 5.4. THROMBECTOMY DEVICES
  • 5.5. EMBOLIC PROTECTION DEVICES

6. MARKET BY APPLICATION

  • 6.1. ANEURYSM
  • 6.2. ISCHEMIC STROKE
  • 6.3. STENOSIS
  • 6.4. ARTERIOVENOUS MALFORMATION (AVM)
  • 6.5. OTHER APPLICATIONS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. ASIA-PACIFIC
    • 7.1.1. MARKET SIZE & ESTIMATES
    • 7.1.2. KEY GROWTH ENABLERS
    • 7.1.3. KEY CHALLENGES
    • 7.1.4. KEY PLAYERS
    • 7.1.5. COUNTRY ANALYSIS
      • 7.1.5.1. CHINA
      • 7.1.5.2. JAPAN
      • 7.1.5.3. AUSTRALIA & NEW ZEALAND
      • 7.1.5.4. INDIA
      • 7.1.5.5. SOUTH KOREA
      • 7.1.5.6. THAILAND
      • 7.1.5.7. INDONESIA
      • 7.1.5.8. VIETNAM
      • 7.1.5.9. REST OF ASIA-PACIFIC

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
  • 8.2. COMPANY PROFILES
    • 8.2.1. ACANDIS GMBH
    • 8.2.2. ASAHI INTECC
    • 8.2.3. B BRAUN MELSUNGEN AG
    • 8.2.4. INTEGER HOLDINGS CORPORATION
    • 8.2.5. JOHNSON & JOHNSON (CERENOVUS)
    • 8.2.6. KANEKA CORPORATION
    • 8.2.7. MEDTRONIC INC
    • 8.2.8. MEMRY CORPORATION
    • 8.2.9. MICROPORT SCIENTIFIC CORPORATION
    • 8.2.10. PENUMBRA INC
    • 8.2.11. PHENOX GMBH
    • 8.2.12. RAPID MEDICAL
    • 8.2.13. SENSOME
    • 8.2.14. STRYKER CORPORATION
    • 8.2.15. TERUMO MEDICAL CORPORATION (MICROVENTION INC)

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - NEUROVASCULAR DEVICES
  • TABLE 2: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: LEADING PLAYERS OPERATING IN THE ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET
  • TABLE 9: LIST OF MERGERS & ACQUISITIONS
  • TABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 11: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 12: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT, IN 2020
  • FIGURE 6: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIZATION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 7: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY ACCESSORY DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 8: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY REVASCULARIZATION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 9: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY THROMBECTOMY DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 10: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 11: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY APPLICATION, IN 2020
  • FIGURE 12: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM, 2021-2028 (IN $ MILLION)
  • FIGURE 13: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY ISCHEMIC STROKE, 2021-2028 (IN $ MILLION)
  • FIGURE 14: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY STENOSIS, 2021-2028 (IN $ MILLION)
  • FIGURE 15: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2021-2028 (IN $ MILLION)
  • FIGURE 16: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 17: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 18: CHINA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 19: JAPAN NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 20: AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 21: INDIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 22: SOUTH KOREA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 23: THAILAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 24: INDONESIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 25: VIETNAM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 26: REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
Back to Top